Net profit of Lincoln Pharmaceuticals declined 24.12% to Rs 19.98 crore in the quarter ended September 2025 as against Rs 26.33 crore during the previous quarter ended September 2024. Sales rose 1.33% to Rs 163.36 crore in the quarter ended September 2025 as against Rs 161.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales163.36161.21 1 OPM %15.5717.60 - PBDT32.4338.01 -15 PBT28.8134.78 -17 NP19.9826.33 -24 Powered by Capital Market - Live News

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Lincoln Pharmaceuticals announced that the 31st Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net profit of Lincoln Pharmaceuticals rose 16.94% to Rs 27.68 crore in the quarter ended June 2025 as against Rs 23.67 crore during the previous quarter ended June 2024. Sales rose 4.61% to Rs 154.07 crore in the quarter ended June 2025 as against Rs 147.28 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales154.07147.28 5 OPM %15.4515.43 - PBDT38.8732.70 19 PBT35.3929.48 20 NP27.6823.67 17 Powered by Capital Market - Live News

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live News